X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TTK HEALTHCARE - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TTK HEALTHCARE NOVARTIS/
TTK HEALTHCARE
 
P/E (TTM) x 393.4 32.9 1,193.9% View Chart
P/BV x 19.4 6.1 319.2% View Chart
Dividend Yield % 1.5 0.5 311.1%  

Financials

 NOVARTIS   TTK HEALTHCARE
EQUITY SHARE DATA
    NOVARTIS
Mar-16
TTK HEALTHCARE
Mar-14
NOVARTIS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs982663 148.0%   
Low Rs556399 139.4%   
Sales per share (Unadj.) Rs252.9535.6 47.2%  
Earnings per share (Unadj.) Rs62.115.9 389.7%  
Cash flow per share (Unadj.) Rs63.320.0 316.1%  
Dividends per share (Unadj.) Rs10.004.00 250.0%  
Dividend yield (eoy) %1.30.8 172.7%  
Book value per share (Unadj.) Rs363.6137.6 264.2%  
Shares outstanding (eoy) m31.967.77 411.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.01.0 306.6%   
Avg P/E ratio x12.433.3 37.2%  
P/CF ratio (eoy) x12.226.5 45.8%  
Price / Book Value ratio x2.13.9 54.8%  
Dividend payout %16.125.1 64.1%   
Avg Mkt Cap Rs m24,5804,127 595.5%   
No. of employees `0000.81.7 44.0%   
Total wages/salary Rs m1,801607 296.9%   
Avg. sales/employee Rs Th10,748.92,436.7 441.1%   
Avg. wages/employee Rs Th2,395.2355.2 674.4%   
Avg. net profit/employee Rs Th2,641.172.5 3,640.8%   
INCOME DATA
Net Sales Rs m8,0834,162 194.2%  
Other income Rs m82961 1,355.2%   
Total revenues Rs m8,9134,223 211.0%   
Gross profit Rs m234197 118.8%  
Depreciation Rs m3732 115.8%   
Interest Rs m230 6.0%   
Profit before tax Rs m1,025197 521.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m75273 1,033.0%   
Profit after tax Rs m1,986124 1,603.0%  
Gross profit margin %2.94.7 61.2%  
Effective tax rate %73.437.0 198.2%   
Net profit margin %24.63.0 825.3%  
BALANCE SHEET DATA
Current assets Rs m12,6781,629 778.4%   
Current liabilities Rs m2,4331,058 230.0%   
Net working cap to sales %126.713.7 923.9%  
Current ratio x5.21.5 338.4%  
Inventory Days Days3330 109.8%  
Debtors Days Days2234 66.9%  
Net fixed assets Rs m69556 12.4%   
Share capital Rs m16078 205.7%   
"Free" reserves Rs m11,460878 1,304.8%   
Net worth Rs m11,6211,069 1,086.8%   
Long term debt Rs m0159 0.0%   
Total assets Rs m14,4002,399 600.1%  
Interest coverage x570.57.6 7,527.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.7 32.4%   
Return on assets %13.86.4 215.4%  
Return on equity %17.111.6 147.5%  
Return on capital %23.618.5 127.8%  
Exports to sales %0.70.8 94.2%   
Imports to sales %18.61.4 1,327.1%   
Exports (fob) Rs m6033 183.0%   
Imports (cif) Rs m1,50358 2,577.5%   
Fx inflow Rs m18633 566.3%   
Fx outflow Rs m1,82163 2,881.5%   
Net fx Rs m-1,635-30 5,396.2%   
CASH FLOW
From Operations Rs m2,531127 1,999.1%  
From Investments Rs m-8,270-146 5,664.2%  
From Financial Activity Rs m-38622 -1,761.2%  
Net Cashflow Rs m-6,1253 -244,980.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 3.7 54.1%  
FIIs % 1.6 5.2 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.8 83.3%  
Shareholders   41,647 12,723 327.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   IPCA LABS  GSK PHARMA  PANACEA BIOTECH  MERCK LTD  SANOFI INDIA  

Compare NOVARTIS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 19, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - MERCK LTD COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS